Net Cash Provided by (Used in) Operating Activities in USD of Inmune Bio, Inc. from 2017 to Q1 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Inmune Bio, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2017 to Q1 2025.
- Inmune Bio, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$6.82M, a 8.72% increase year-over-year.
- Inmune Bio, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$33.4M, a 178% decline from 2023.
- Inmune Bio, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$12M, a 47.2% increase from 2022.
- Inmune Bio, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$22.7M, a 20.4% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)